TLR9 and hepatocellular carcinoma: Research found genetic ablation of TLR9 reduced idiopathic liver injury, fibrosis and hepatocellular carcinoma (HCC) in hepatic deletion of TGF-β-activated kinase 1 (Tak1ΔHep) mice [50].